Unboxing AI | Friday Webinars @ 11 AM ET | Dr Leonardo K Bittencourt, University Hospitals (July 12) | Kevin Harris, CureMetrix (July 19) | Dr Ryan Lee, Jefferson Health (July 26) | Register Now
  • 2019-10-01

Concepts in US Food and Drug Administration regulation of artificial intelligence for medical imaging

OBJECTIVE

Although extensive attention has been focused on the enormous potential of artificial intelligence (AI) technology, a major question remains: how should this fundamentally new technology be regulated? The purpose of this article is to provide an overview of the pathways developed by the U.S. Food and Drug Administration to regulate the incorporation of AI in medical imaging.

CONCLUSION

AI is the new wave of innovation in health care. The technology holds promising applications to revolutionize all aspects of medicine.

Link to complete publication here:https://scholar.google.com/citations?view_op=view_citation&hl=en&user=dqpMNRUAAAAJ&citation_for_view=dqpMNRUAAAAJ:qjMakFHDy7sC

Unlock the potential of CARPL platform for optimizing radiology workflows

Talk to a Clinical Solutions Architect